Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663

Watchlist Manager
Bharat Immunologicals and Biologicals Corporation Ltd Logo
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Watchlist
Price: 23.21 INR -1.36% Market Closed
Market Cap: 1B INR
Have any thoughts about
Bharat Immunologicals and Biologicals Corporation Ltd?
Write Note

Bharat Immunologicals and Biologicals Corporation Ltd
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bharat Immunologicals and Biologicals Corporation Ltd
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Other Current Assets
â‚ą123.5m
CAGR 3-Years
-2%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Other Current Assets
â‚ą8.4m
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Other Current Assets
â‚ą9.8m
CAGR 3-Years
30%
CAGR 5-Years
-12%
CAGR 10-Years
20%
Hester Biosciences Ltd
NSE:HESTERBIO
Other Current Assets
â‚ą197.9m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Other Current Assets
â‚ą3B
CAGR 3-Years
-14%
CAGR 5-Years
4%
CAGR 10-Years
12%
Panacea Biotec Ltd
NSE:PANACEABIO
Other Current Assets
â‚ą674.3m
CAGR 3-Years
-16%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
No Stocks Found

Bharat Immunologicals and Biologicals Corporation Ltd
Glance View

Market Cap
1B INR
Industry
Biotechnology

Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacture and market of pharmaceutical products. The company is headquartered in Bulandshahr, Uttar Pradesh. The firm is primarily engaged in the manufacture of Oral polio Vaccine, Zinc Tablets, Diarrhea management Kit and BIB Sweet Tablets. The company is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The firm is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). The company is also diversified into Plasma-derived medicines and Oral Cholera vaccines. The firm's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.

BIBCL Intrinsic Value
5.26 INR
Overvaluation 77%
Intrinsic Value
Price

See Also

What is Bharat Immunologicals and Biologicals Corporation Ltd's Other Current Assets?
Other Current Assets
123.5m INR

Based on the financial report for Sep 30, 2023, Bharat Immunologicals and Biologicals Corporation Ltd's Other Current Assets amounts to 123.5m INR.

What is Bharat Immunologicals and Biologicals Corporation Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
52%

Over the last year, the Other Current Assets growth was -12%. The average annual Other Current Assets growth rates for Bharat Immunologicals and Biologicals Corporation Ltd have been -2% over the past three years , 52% over the past five years .

Back to Top